Revocation of New York Ruling Letter H85059; classification of monoclonal antibody medicaments
Reasoning
Revocation of New York Ruling Letter H85059; classification of monoclonal antibody medicaments
Cite this ruling
CBP Ruling H128157 (30021001): Revocation of New York Ruling Letter H85059; classification of monoclonal antibody medicaments
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 300210
The tariff classification of AGN-150894 Anticalins from Germany
The tariff classification of Anti-beta Actin antibody [mAbcam 8226], from the United States
The tariff classification of Anti-Actin antibody [EPR16769] ab179467, from China
Revocation of New York Ruling Letter L80355; classification of Thymoglobulin® [Anti-thymocyte Globulin (Rabbit)] Sterile Lyophilized Preparation, imported from France
The tariff classification of a rabbit polyclonal antibody from United Kingdom